Forty percent of all cancers are associated with modifiable risk factors, though there has been a 33% decline in the cancer death rate between 1991 and 2021, according to the American Association for Cancer Research's annual Cancer Progress Report.
Author: Elizabeth Gregerson
Duarte, Calif.-based City of Hope has received a $150 million gift to fund pancreatic cancer research, the single largest gift in the health system's history, from philanthropists A. Emmet Stephenson Jr. and Tessa Stephenson Brand.
As pharmaceutical innovation for oncology care continues to grow, here are four updates to know:
Memorial Sloan Kettering Cancer Center in New York City has appointed two oncology chiefs.
Individuals are at an increased risk of cardiovascular disease and psychological illness after a family member is diagnosed with cancer, according to a study published Sept. 9 in Cancer.
Advertisement
University of Texas MD Anderson Cancer Center and Rice University, both based in Houston, have partnered to launch a new operational research initiative aimed at improving cancer care operations with data.
Surgeons at the Camden, N.J.-based MD Anderson Cancer Center at Cooper employed noninvasive, histotripsy technology for the treatment of liver cancer, becoming one of 20 cancer centers in the world to offer the treatment.
A team from Memorial Sloan Kettering Cancer Center in New York City identified a new, rare form of small cell lung cancer, found primarily in patients who have no history of smoking.
Flagstaff-based Northern Arizona Healthcare has partnered with Phoenix-based City of Hope to offer advanced treatment options and expertise to NAH patients with complex or rare types of cancer closer to home.
The American Society of Clinical Oncology has publicly urged CMS to ensure patient access to CAR T-cell therapy in response to the agency's proposed 2025 Hospital Outpatient Prospective Payment System plan.